Aminolevulinic acid HCl 20 % Topical Solution
RxNorm 762672
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 762672 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: aminolevulinic acid HCl 20 % Topical Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Aminolevulinate 200 mg/ML Topical Solution
(Atom ID: 12329987)
SYPrescribable
Synonym (SY):
Aminolevulinate 20 % Topical Solution
(Atom ID: 6394532)
PSNPrescribable
Prescribable Name (PSN):
Aminolevulinic acid HCl 20 % Topical Solution
(Atom ID: 6394531)
PTPrescribable
Designated preferred name (PT):
Aminolevulinic acid hydrochloride 200 mg/mL cutaneous solution
(Atom ID: 11435189)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely aminolevulinic acid hydrochloride 200 mg/1 mL conventional release cutaneous solution (clinical drug)
(Atom ID: 11439150)
Patient Education
Aminolevulinic Acid Topical
Aminolevulinic acid is used in combination with photodynamic therapy (PDT; special blue light) to treat actinic keratoses (small crusty or scaly bumps or horns on or under the skin that result from exposure to sunlight and can develop into skin cancer) of the face or scalp. Aminolevulinic acid is in a class of medications called photosensitizing agents. When aminolevulinic acid is activated by light, it damages the cells of actinic keratosis lesions.
[Learn More]
* Please review the disclaimer below.